No abstract

As an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy. (ClinicalTrials.gov number, NCT00007657 [ClinicalTrials.gov].).

The disclosure forms of all experts involved in the development of this Expert Consensus Document are available on the ESC website www.escardio.org/guidelines ESC Guidelines

No abstract

No abstract